Max Planck Institute of Biochemistry, Department of Proteomics and Signal Transduction, München, Germany
Max Planck Institute of Biochemistry, Department of Proteomics and Signal Transduction, München, Germany
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal adenocarcinoma, esophageal cancer, esophageal disorder, neoplasm | Active, not recruiting | Not stated | 2024-11-12 | NCT06642506 |